- Accesswire•2 hours agoResearch Reports Initiated on Healthcare Stocks Knight Therapeutics, Valeant Pharmaceuticals International, Merus Labs International, and Canopy Growth
LONDON, UK / ACCESSWIRE / January 18, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected ...
- The Wall Street Journal•16 hours ago
Allergan will pay $15 million in fines and admit to disclosure violations during a hostile takeover bid from Valeant Pharmaceuticals.
- Reuters•16 hours ago
A unit of Botox maker Allergan Plc will pay a $15 million penalty and admit to wrongdoing, after U.S. regulators on Tuesday accused the unit of failing to disclose 2014 merger talks with Actavis, the U.S. Securities and Exchange Commission said. In a statement on Tuesday, the SEC said that the disclosure failures occurred in the months after the company received a tender offer from Valeant Pharmaceuticals International and co-bidder Pershing Square Capital Management, the hedge fund run by Bill Ackman.
VRX.TO : Summary for VALEANT PHARMACEUTICALS INTL IN - Yahoo Finance
Valeant Pharmaceuticals International, Inc. (VRX.TO)
Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||20.00 - 20.06|
|52 Week Range||17.42 - 142.35|
|PE Ratio (TTM)||-3.05|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|